e-learning
resources
Munich 2014
Monday, 08.09.2014
Acute pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum apelin 13 levels in patients with pulmonary embolism
H. Selimoglu Sen, I. Kaplan, O. Abakay, C. Sezgi, S. Yilmaz, M. Taylan, A. C. Tanrikulu, A. Abakay (Diyarbakir, Turkey)
Source:
International Congress 2014 – Acute pulmonary embolism
Session:
Acute pulmonary embolism
Session type:
Thematic Poster Session
Number:
2397
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Selimoglu Sen, I. Kaplan, O. Abakay, C. Sezgi, S. Yilmaz, M. Taylan, A. C. Tanrikulu, A. Abakay (Diyarbakir, Turkey). Serum apelin 13 levels in patients with pulmonary embolism. Eur Respir J 2014; 44: Suppl. 58, 2397
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Alteration of factors associated with coagulation in provoked pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Clinical phenotypes in pulmonary emboli identified by cluster analysis
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Would RDW be a prognostic factor in pulmonary arterial hypertension?
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Characterization of circulating CD133+ progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014
Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Do persistent perfusion defects predict late recurrences in pulmonary embolism?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Endothelial-to-mesenchymal transition in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Th17 inflammation and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Exercise-induced pulmonary pressure changes in scleroderma patients – A follow-up study
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014
Endothelial microparticles and progenitor cells in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Chronic thromboembolic vasculopathy with exercise induced PH but normal resting haemodynamics
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept